HomeAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$2.58
After Hours:(1.52%)+0.039
$2.62
Closed: Oct 17, 6:06:44 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$2.62
Day range
$2.55 - $2.66
Year range
$2.33 - $20.35
Market cap
6.99M USD
Avg Volume
128.52K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 25.00K | -50.00% |
Operating expense | 2.66M | -28.77% |
Net income | -2.79M | -52.18% |
Net profit margin | -11.18K | -204.36% |
Earnings per share | -3.68 | -22.67% |
EBITDA | -2.59M | 28.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 835.00K | -91.70% |
Total assets | 4.13M | -73.73% |
Total liabilities | 10.68M | 11.05% |
Total equity | -6.55M | — |
Shares outstanding | 2.71M | — |
Price to book | -0.31 | — |
Return on assets | -127.49% | — |
Return on capital | 260.64% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.79M | -52.18% |
Cash from operations | -1.53M | 49.10% |
Cash from investing | 754.00K | -8.72% |
Cash from financing | 355.00K | -85.46% |
Net change in cash | -422.00K | -262.93% |
Free cash flow | -1.37M | 65.91% |
About
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Founded
1966
Headquarters
Website
Employees
22
